Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean energy stock picks.

Over the past few years, Axsome Therapeutics has made slow and steady clinical and regulatory progress. The company's lineup of approved products now features Auvelity for depression, Symbravo for migraines, and Sunosi for daytime sleepiness due to narcolepsy, which it acquired from Jazz Pharmaceuticals.

FCF valuation, +10.55% return. 17 stocks appear potentially undervalued, while 7 saw valuation downgrades. See more.

European stocks fell on Thursday, dragged down by a selloff in tech and disappointing updates from several heavyweight retailers, while weaker gold and copper prices weighed on broader market mood. The retreat cools the early‑2026 rally in the pan‑European STOXX 600,

UBS raises Micron stock target to $400 as AI memory demand exceeds supply. Micron and Alphabet offer different paths to AI infrastructure growth.

Amazon (NASDAQ:AMZN) may be the dominant e-commerce retailer that’s pushed big retail to adapt or crumble under pressure, but with the firm now boasting a $2.6 trillion market cap, it isn’t the same growth star it used to be.

Makers of cooling systems saw their stocks sell off Tuesday after comments by Nvidia Corp.’s chief executive raised fears about demand for their products from data centers.

Here are three potentially unstoppable artificial intelligence stocks to buy for 2026.